БЛОГ

Archive for the ‘life extension’ category: Page 385

Jun 21, 2019

Positive Results from Urolithin A Human Trial

Posted by in category: life extension

In a small, recent human trial, a naturally occurring compound called urolithin A has yielded positive results and appears to slow down part of the aging process that is related to the production of energy in our cells.

What is urolithin A?

Urolithin A is the end product created when bacteria in the gut break down ellagitannins, which are polyphenols found in fruits such as pomegranates, strawberries, walnuts, and raspberries. The substance does not appear naturally in its end form, so we normally rely on the beneficial bacteria in the microbiome, our internal ecology of gut bacteria, to convert the polyphenols into urolithin A.

Jun 19, 2019

Submission to the Immortality Project conducted by University of California, Riverside – Dr Janni Lloyd

Posted by in categories: biotech/medical, life extension, quantum physics

I’m Dr Janni Lloyd. My interest in health formally began in 1973 when I commenced my medical degree at the University of Western Australia. I spent many years in General Practice with a special interest in the psychological and emotional aspects of health maintenance and disease creation. In 1994 I moved into Holistic / Alternative / Complementary health. In 1992 I began studying Healthy Longevity / Indefinite Life Extension and the philosophy of Physical Immortality from many different perspectives – spirituality/theology, holistic health, psychology, medical science and quantum physics.

The following essay/article combines many of these different viewpoints.

HEALTHY LIFE EXTENSION / PHYSICAL IMMORTALITY – THE MASS POSSIBILITY

Jun 19, 2019

Dr. Dennis McKenna — ideaXme — Psychedelic Drugs in Mainstream Medicine — Ira Pastor

Posted by in categories: aging, bioengineering, biotech/medical, business, chemistry, finance, health, life extension, neuroscience

Jun 19, 2019

Biotech Investing in Longevity Panel 2: Aubrey de Grey, Gordon Lithgow, Mike West

Posted by in categories: biotech/medical, life extension

Collaborate toward positive futures: https://www.existentialhope.com/

Jun 19, 2019

Eating Cheese Could Actually Make You Live Longer, Science Says

Posted by in categories: biotech/medical, food, life extension, science

a woman eating a slice of pizza: A study published in the journal Nature Medicine found that eating cheese can lead to a longer lifespan. © Provided by Bauer Media Pty Ltd A study published in the journal Nature Medicine found that eating cheese can lead to a longer lifespan.

Every now and again, a study is released that makes our heart skip a beat.

Recently, research published in the journal Nature Medicine found that eating cheese can lead to a longer lifespan (and it wasn’t even satire!).

Jun 19, 2019

Podcast Special Edition Mini-Cast: Preview of The 2019 Ending-Age Related Diseases Conference

Posted by in categories: biotech/medical, life extension

“As far as I’m concerned, ageing is humanity’s worst problem, by some serious distance.”–Aubrey de Grey.

Jun 19, 2019

Michio Kaku: Genetic and digital immortality are within reach

Posted by in categories: genetics, life extension

https://youtu.be/STisIGbJIAI via @michiokaku

Jun 18, 2019

Interview with Prof. Morgan Levine

Posted by in categories: biological, genetics, life extension

Tam Hunt interviews Prof. Morgan Levine about her work with epigenetics and aging.


One of the biggest breakthroughs in biology in the last few decades has been the discovery of epigenetics. Rather than changing the genes themselves, epigenetics change how genes are expressed, allowing our cells to differentiate between their various types.

However, the epigenetics of our cells change over time. There is some debate over how much epigenetic alterations are a cause or a consequence of other age-related damage, but they are one of the primary hallmarks of aging.

Continue reading “Interview with Prof. Morgan Levine” »

Jun 18, 2019

The Future of Pensions – Article

Posted by in categories: biotech/medical, geopolitics, life extension, policy, transhumanism

Editor’s Note: The U.S. Transhumanist Party features this article by Nicola Bagalà and Michael Nuschke of the Life Extension Advocacy Foundation (LEAF), originally published on the LEAF site on May 15th, 2019. The article brings attention to and responds to concerns related to the impacts of increased longevity on pension systems, a possible result of our mission of ending age-related diseases, which the U.S. Transhumanist Party supports as part of our policy goals.

~ Brent Reitze, Director of Publication, United States Transhumanist Party, June 15th, 2019

If you work in social security, it’s possible that your nightmares are full of undying elderly people who keep knocking on your door for pensions that you have no way of paying out. Tossing and turning in your bed, you beg for mercy, explaining that there’s just too many old people who need pensions and not enough young people who could cover for it with their contributions; the money’s just not there to sustain a social security system that, when it was conceived in the mid-1930s, didn’t expect that many people would ever make it into their 80s and 90s. Your oneiric persecutors won’t listen: they gave the country the best years of their lives, and now it’s time for the country to pay them their due.

Jun 18, 2019

UNITY Biotechnology Reports Promising Topline Data from Phase 1 First-in-human Study of UBX0101 in Patients with Osteoarthritis of the Knee

Posted by in categories: biotech/medical, life extension

It’s a start. So far so good, senolytics.


SAN FRANCISCO, June 18, 2019 (GLOBE NEWSWIRE) — UNITY Biotechnology, Inc. (UNITY) [NASDAQ: UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or reversing diseases of aging, today announced promising results from its first-in-human Phase 1 study of UBX0101 in patients with moderate to severe osteoarthritis (OA) of the knee. The study demonstrated that UBX0101 was safe and well-tolerated. Improvement in several clinical measures, including pain, function, as well as modulation of certain senescence-associated secretory phenotype (SASP) factors and disease-related biomarkers was observed after a single dose of UBX0101.